Merck & Co., Inc. (MRK) vs Thermo Fisher Scientific Inc. (TMO): Which Is the Better Buy in 2026?
As of 2026-06-19, MRK is undervalued at $114, with a DCF intrinsic value of $597 and a margin of safety of 81%. TMO is overvalued at $465, with an intrinsic value of $407 and a margin of safety of -14%. Of the two, MRK has the wider margin of safety.
Rewards
- ★Gross margin of 76.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
- ★Each dollar of retained earnings has created $4.94 of earning power — management is an exceptional capital allocator.
- ★Management has timed buybacks well — 2 out of 3 years showed value-accretive repurchases.
- ★Trailing P/E of 25.5x is 21% below the historical average of 32.3x — potentially undervalued relative to its own history.
- ★Altman Z-Score of 3.85 indicates very low bankruptcy risk — the company is firmly in the safe zone.
Risks
- ⚠PEG ratio of 5.36 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
- ⚠14 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.
- ⚠Free cash flow has declined at a 5.6% CAGR over the past 4 years — a concerning trend.
- ⚠21 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.
Key Valuation Metrics
Learn more →Historical Fundamentals
Learn more →Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.
Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.
Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.
$1 Retained Earnings Test
Learn more →> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
Discounted Cash Flow (DCF) Analysis
Learn more →Reverse DCF — Market-Implied Growth
Learn more →What growth rate is the market pricing in at $114?
The market implies +4.9% Owner Earnings growth, below historical trends — potential opportunity.
Standard FCF implies a more demanding +9.7%, reflecting heavy growth investment expected to generate future returns.
What growth rate is the market pricing in at $465?
The market implies +11.6% Owner Earnings growth, above historical trends.
Standard FCF implies a demanding +16.6%, reflecting heavy growth investment.
Economic Moat Score
Learn more →Narrow moat with revenue predictability as the key competitive advantage. Improving margin stability would strengthen the moat.
Narrow moat with margin stability as the key competitive advantage. Improving roic consistency would strengthen the moat.
Forensic Accounting
Learn more →M-Score Trend
M-Score Trend
Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
Ownership Breakdown
Learn more →High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.
Insider Buying Activity
Learn more →Open market purchases · includes direct & indirect ownership · excludes option exercises.
Insider Selling Activity
Learn more →Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.
🎭 Mr. Market's Mood
Learn more →"Market is pricing this stock without strong emotion in either direction"
"Market is pessimistic — investigate whether fears are temporary or structural"
Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
⚖️ Buffett Signal
Learn more →The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.
The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.
Frequently Asked Questions: MRK vs TMO
Is Merck & Co., Inc. or Thermo Fisher Scientific Inc. more undervalued in 2026?▼
Based on our discounted cash flow model, MRK trades at a 80.9% margin of safety (intrinsic value $597 vs. price $114), compared to TMO's -14.3% margin of safety (intrinsic $407 vs. $465).
Which stock has a wider economic moat, Merck & Co., Inc. or Thermo Fisher Scientific Inc.?▼
MRK scores 68/100 (Narrow moat), while TMO scores 60/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.
Which company has better free cash flow, Merck & Co., Inc. or Thermo Fisher Scientific Inc.?▼
Merck & Co., Inc. (MRK) generates a 5.0% free cash flow yield, compared to Thermo Fisher Scientific Inc.'s 3.2%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.
Which stock has higher return on invested capital, Merck & Co., Inc. or Thermo Fisher Scientific Inc.?▼
MRK earns 21.1% ROIC versus TMO's 6.7%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.
Which dividend is safer, Merck & Co., Inc.'s or Thermo Fisher Scientific Inc.'s?▼
TMO's dividend earns a safety score of 94/100 (Very Safe), compared to MRK's 79/100 (Safe). TMO has raised its dividend for 3 consecutive years.